These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26580161)

  • 21. Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family.
    Vietri MT; Molinari AM; Caliendo G; De Paola ML; Giovanna D; Gambardella AL; Petronella P; Cioffi M
    Clin Chem Lab Med; 2013 Dec; 51(12):2319-24. PubMed ID: 23940062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environment and genetics: Making sense of the noise.
    Petherick A
    Nature; 2012 May; 485(7400):S64-5. PubMed ID: 22648504
    [No Abstract]   [Full Text] [Related]  

  • 23. Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies.
    Long KC; Kauff ND
    Curr Opin Oncol; 2011 Sep; 23(5):526-30. PubMed ID: 21734577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?
    Smith MJ; Gifford FL; Lalloo F; Newman WG; Evans DG
    Breast Cancer Res Treat; 2012 Jul; 134(2):895-7. PubMed ID: 22752287
    [No Abstract]   [Full Text] [Related]  

  • 25. Breast cancer: 4 big questions.
    Woolston C
    Nature; 2015 Nov; 527(7578):S120. PubMed ID: 26580163
    [No Abstract]   [Full Text] [Related]  

  • 26. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes.
    Wang Q
    Acta Pharmacol Sin; 2016 Feb; 37(2):143-9. PubMed ID: 26616728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.
    Konstantopoulou I; Tsitlaidou M; Fostira F; Pertesi M; Stavropoulou AV; Triantafyllidou O; Tsotra E; Tsiftsoglou AP; Tsionou C; Droufakou S; Dimitrakakis C; Fountzilas G; Yannoukakos D
    Clin Genet; 2014 Jan; 85(1):36-42. PubMed ID: 24010542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thank you for sharing.
    Nature; 2015 Apr; 520(7549):585. PubMed ID: 25925435
    [No Abstract]   [Full Text] [Related]  

  • 30. [Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].
    Pujol P; This P; Noruzinia M; Stoppa-Lyonnet D; Maudelonde T
    Bull Cancer; 2004; 91(7-8):583-91. PubMed ID: 15381448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of Inquiry-Based Stress Reduction (IBSR) technique for BRCA1/2 mutation carriers.
    Landau C; Lev-Ari S; Cohen-Mansfield J; Tillinger E; Geva R; Tarrasch R; Mitnik I; Friedman E
    Psychooncology; 2015 Jun; 24(6):726-31. PubMed ID: 25328041
    [No Abstract]   [Full Text] [Related]  

  • 32. Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.
    Laitman Y; Vaisman Y; Feldman D; Helpman L; Gitly M; Paluch Shimon S; Berger R; Cohen L; Narod SA; Friedman E
    Clin Genet; 2014 Jan; 85(1):68-71. PubMed ID: 23517234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
    Loman N
    Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
    Patenaude AF; Tung N; Ryan PD; Ellisen LW; Hewitt L; Schneider KA; Tercyak KP; Aldridge J; Garber JE
    Psychooncology; 2013 Sep; 22(9):2024-31. PubMed ID: 23417902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of family risk and lifestyle/comorbidities in ovarian cancer patients.
    Teixeira N; Folgueira MA; Maistro S; Encinas G; Bock GH; Diz Mdel P
    Rev Assoc Med Bras (1992); 2015; 61(3):234-9. PubMed ID: 26248245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging, risk assessment and screening of breast cancer.
    Yalcin B
    Exp Oncol; 2013 Dec; 35(4):238-45. PubMed ID: 24382431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.
    Yablonski-Peretz T; Paluch-Shimon S; Gutman LS; Kaplan Y; Dvir A; Barnes-Kedar I; Kadouri L; Semenisty V; Efrat N; Neiman V; Glasser Y; Michaelson-Cohen R; Katz L; Kaufman B; Golan T; Reish O; Hubert A; Safra T; Yaron Y; Friedman E
    Breast Cancer Res Treat; 2016 Jan; 155(1):133-8. PubMed ID: 26687385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    Meaney-Delman D; Bellcross CA
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.